United States Government Publishing Office
publisher
pbl
distributor
dst
United States
National Archives and Records Administration
Office of the Federal Register
author
aut
Government Organization
text
government publication
eng
FR
Regulatory Information
2004_register
executive
2010-09-23
article
Medicare Program; Open Public Meeting Regarding the Development of the Model Guidelines for Categories and Classes of Drugs
Notices
D09002ee1bde8a583
D09002ee1bde8a629
United States
Department of Health and Human Services
originator
org
United States Government Agency or Subagency
United States
Centers for Medicare & Medicaid Services
originator
org
United States Government Agency or Subagency
This notice announces a public meeting to provide pharmaceutical benefit managers and other interested parties, an opportunity to provide individual comments on the Model Guidelines for Classes and Categories of Drugs (Model Guidelines) developed by the United States Pharmacopeia (USP). Interested parties include beneficiaries, advocacy groups, managed care organizations, trade and professional associations, prescription drug plans, healthcare practitioners, providers, pharmaceutical manufacturers, and others. USP is a nongovernmental organization, as set forth under the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA). The MMA provides for the development of Model Guidelines by USP in consultation with pharmaceutical benefit managers and other interested parties.
69 FR 45822
https://www.govinfo.gov/app/details/FR-2004-07-30/04-17237
04-17237
fr30jy04-110
4120-01-P
CMS-4068-N
https://www.govinfo.gov/app/details/FR-2004-07-30/04-17237
https://www.govinfo.gov/content/pkg/FR-2004-07-30/html/04-17237.htm
https://www.govinfo.gov/content/pkg/FR-2004-07-30/pdf/04-17237.pdf
2 p.
45822
45823
69 FR 45822
Medicare Program; Open Public Meeting Regarding the Development of the Model Guidelines for Categories and Classes of Drugs; Federal Register Vol. 69, Issue
NOTICE
04-17237
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
2004-08-27
CMS-4068-N
4120-01-P
04-17237
Notice of meeting.
This notice announces a public meeting to provide pharmaceutical benefit managers and other interested parties, an opportunity to provide individual comments on the Model Guidelines for Classes and Categories of Drugs (Model Guidelines) developed by the United States Pharmacopeia (USP). Interested parties include beneficiaries, advocacy groups, managed care organizations, trade and professional associations, prescription drug plans, healthcare practitioners, providers, pharmaceutical manufacturers, and others. USP is a nongovernmental organization, as set forth under the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA). The MMA provides for the development of Model Guidelines by USP in consultation with pharmaceutical benefit managers and other interested parties.
The meeting is scheduled for August 27, 2004, from 9 a.m. until 4 p.m. e.d.t. This meeting is open to the public.
Kelly Coates, United States Pharmacopeia at 12601 Twinbrook Parkway, Rockville, MD 20852, conferences@usp.org, (301) 816-8130.
Meetings:
Medicare
Drug categories and classes; model guidelines development,
conferences@usp.org
ktc@usp.org
lfl@usp.org
www.usp.org/conferences
Federal Register
Vol. 69, no. 146
Office of the Federal Register, National Archives and Records Administration
2004-07-30
continuing
daily
deposited
born digital
551 p.
Table of Contents:
AE 2.7:
GS 4.107:
AE 2.106:
KF70.A2
https://www.govinfo.gov/app/details/FR-2004-07-30
P0b002ee180983f71
0097-6326
0042-1219
0364-1406
769-004-00000-9
000582072
f:fr30jy04
https://www.govinfo.gov/app/details/FR-2004-07-30
https://www.govinfo.gov/content/pkg/FR-2004-07-30/pdf/FR-2004-07-30.pdf
https://www.govinfo.gov/content/pkg/FR-2004-07-30/xml/FR-2004-07-30.xml
fdlp
45555
46093
DGPO
2010-09-23
2023-05-03
FR-2004-07-30
machine generated
eng
FR
FR-2004-07-30
69
146